One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010: An Observational Study
Overview
Neurology
Authors
Affiliations
Background And Purpose: Recent data on the incidence, time trends, and predictors of recurrent ischemic stroke are limited for unselected patient populations.
Methods: Data for ischemic stroke patients were obtained from The Swedish Stroke Register (Riksstroke) between 1998 and 2009 and merged with The Swedish National Inpatient Register. A reference group of patients was created by Statistics Sweden. The ischemic stroke patient cohort was divided into 4 time periods. Recurrent ischemic stroke within 1 year was recorded until 2010. Kaplan-Meier and Cox regression analyses were performed to study time trends and predictors of ischemic stroke recurrence.
Results: Of 196 765 patients with ischemic stroke, 11.3% had a recurrent ischemic stroke within 1 year. The Kaplan-Meier estimates of the 1-year cumulative incidence of recurrent ischemic stroke decreased from 15.0% in 1998 to 2001 to 12.0% in 2007 to 2010 in the stroke patient cohort while the cumulative incidence of ischemic stroke decreased from 0.7% to 0.4% in the reference population. Age >75 years, prior ischemic stroke or myocardial infarction, atrial fibrillation without warfarin treatment, diabetes mellitus, and treatment with β-blockers or diuretics were associated with a higher risk while warfarin treatment for atrial fibrillation, lipid-lowering medication, and antithrombotic treatment (acetylsalicylic acid, dipyridamole) were associated with a reduced risk of recurrent ischemic stroke.
Conclusions: The risk of recurrent ischemic stroke decreased from 1998 to 2010. Well-known risk factors for stroke were associated with a higher risk of ischemic stroke recurrence; whereas, secondary preventive medication was associated with a reduced risk, emphasizing the importance of secondary preventive treatment.
Recurrent Ischemic Stroke and Transient Ischemic Attack: Risk of Single and Multiple Recurrence.
Park M, Lee S, Jung J J Clin Med. 2024; 13(19).
PMID: 39407804 PMC: 11477265. DOI: 10.3390/jcm13195744.
Willeit K, Boehme C, Toell T, Tschiderer L, Seekircher L, Mayer-Suess L JACC Adv. 2024; 3(7):101022.
PMID: 39130023 PMC: 11312770. DOI: 10.1016/j.jacadv.2024.101022.
Chen Y, Zhang Y, Jiang L, Lu Y, Ding X, Jin W Front Neurol. 2024; 15:1365860.
PMID: 38974682 PMC: 11224152. DOI: 10.3389/fneur.2024.1365860.
Patient Readmission for Ischemic Stroke: Risk Factors and Impact on Mortality.
Liu C, Luo L, He X, Wang T, Liu X, Liu Y Inquiry. 2024; 61:469580241241271.
PMID: 38529892 PMC: 10966977. DOI: 10.1177/00469580241241271.
Exploring the Multifaceted Causes of Ischemic Stroke: A Narrative Review.
Gupta C, Wagh V Cureus. 2023; 15(10):e47531.
PMID: 38021859 PMC: 10664821. DOI: 10.7759/cureus.47531.